Pretreatment level of CA 19-9 is a prognostic factor in advanced pancreatic cancer treated with chemotherapy

被引：0
|
作者：
Gansl, R. C. [1 ]
Reis, P. T. [1 ]
Tabacof, J. [1 ]
Simon, S. D. [1 ]
Machado, M. C. [1 ]
Borghesi, G. [1 ]
Saad, E. D. [1 ]
机构：
[1] Dendrix, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15637
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine
    Everardo D. Saad
    Marcel C. Machado
    Dalia Wajsbrot
    Roberto Abramoff
    Paulo M. Hoff
    Jacques Tabacof
    Artur Katz
    Sergio D. Simon
    René C. Gansl
    International Journal of Gastrointestinal Cancer, 2002, 32 : 35 - 41
  • [2] Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine
    Saad, ED
    Machado, MC
    Wajsbrot, D
    Abramoff, R
    Hoff, PM
    Tabacof, J
    Katz, A
    Simon, SD
    Gansl, RC
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 32 (01) : 35 - 41
  • [3] FURTHER EVIDENCE OF THE PROGNOSTIC ROLE OF PRETREATMENT LEVELS OF CA 19-9 IN ADVANCED PANCREATIC CANCER
    Saad, Everardo D.
    Reis, Pedro T.
    Borghesi, Gustavo
    Machado, Marcel C.
    Simon, Sergio D.
    Tabacof, Jacques
    Gansl, Rene C.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2010, 56 (01): : 22 - 26
  • [4] CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer
    Ishii, H
    Okada, S
    Sato, T
    Wakasugi, H
    Saisho, H
    Furuse, J
    Ishikawa, O
    Matsuno, S
    Yokoyama, S
    HEPATO-GASTROENTEROLOGY, 1997, 44 (13) : 279 - 283
  • [5] Prognostic value of CA 19-9 in patients with pancreatic cancer treated with Gemcitabine
    Halm, U
    Schuhmann, T
    Keim, V
    Moessner, J
    GASTROENTEROLOGY, 1999, 116 (04) : A1129 - A1129
  • [6] CA 19-9 level predicts response to GTX chemotherapy in pancreatic cancer.
    Fogelman, DR
    Schreibman, SM
    Fine, RL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 359S - 359S
  • [7] Prognostic value of CA 19-9 level in resectable pancreatic adenocarcinoma
    Rudnicki, J.
    Agrawal, A. K.
    Grzebieniak, Z.
    Zukrowski, P.
    Zysko, D.
    Jelen, M.
    Kielan, W.
    Sebastian, M.
    Slonina, J.
    Marek, G.
    Duda-Barcik, L.
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (02) : 249 - 261
  • [8] Prognostic impact of preoperative serum CA 19-9 level in pancreatic cancer: a pooled analysis
    Mattiucci, G. C.
    Morganti, A. G.
    Farioli, A.
    Frakulli, R.
    Cellini, F.
    Arcelli, A.
    Bertini, F.
    Forni, F.
    Fuccio, L.
    Farina, E.
    Ronchi, L.
    Guido, A.
    Macchia, G.
    Cammelli, S.
    Falconi, M.
    Valentini, V.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S78 - S78
  • [9] CA 19-9 AS A PREDICTOR FOR RESPONSE AND SURVIVAL IN ADVANCED PANCREATIC CANCER PATIENTS TREATED WITH CHEMORADIOTHERAPY
    Koom, Woong Sub
    Seong, Jinsil
    Kim, Yong Bae
    Pyun, Hae Ok
    Song, Si Young
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1148 - 1154
  • [10] Prognostic value of CA 19-9 serum course in pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    HEPATO-GASTROENTEROLOGY, 1998, 45 (19) : 253 - 259
12345